19
Jun
2024

KEXING BIOPHARM CO., LTD.

Exhibitor at CPHI & PMEC China 2024 stand W4P18, Bio Pharma
About Us

Kexing Biopharm integrates R&D, manufacture, and sales of biopharmaceuticals. 
Its production site offers Recombinant Human Erythropoietin Injection(EPO), Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)Filgrastim, and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and commercial use. 
The company develops recombinant genetic biological drugs and micro-ecological preparation, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestin...

  • CN
  • 2022
    On CPHI since
  • 500 - 999
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
Event information
CPHI & PMEC China 2024
  • 19 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand W4P18, Bio Pharma